#tumor

Collection of tumor news, found 81 news.

Guardant Health completes purchase of Guardant Health AMEA joint venture

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the ...

LintonPharm to release data on Catumaxomab for advanced Gastric Cancer with peritoneal metastasis at 2022 ASCO Annual Meeting

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging ...

Microplastics can enter human body through several ways: Expert

Microplastic can enter the human body through several ways, such as via breathing, digestion, and exposure to weathered ...

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

A stitch in time: Taiwan and Japan join hands in providing critical care

Japan has donated five batches of the AZ COVID-19 vaccine to Taiwan, and Taiwan has reciprocated by providing ...

Smoking, obesity can cause kidney cell carcinoma: specialist

Smoking, obesity, and high blood pressure can cause Renal Cell Carcinoma (RCC), a type of kidney cancer, a specialist ...

RubrYc Therapeutics announces Series A2 Preferred equity financing, collaboration, and RTX-003 license with iBio, Inc.

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of ...

Ovarian cysts pose risk to women of all ages: Expert

Dr. Syamel M SpOG K.Onk, Obstetrics and Gynecology Specialist and Consultant Oncology at Semen Padang Hospital, ...

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

NTHU researchers discover new gastric cancer biomarkers for tailored therapy

A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua ...

Mevion partners with Hermes Advanced Therapy Systems to expand reach in Asia

Mevion Medical Systems is pleased to announce it has entered a partnership agreement with Hermes Advanced Therapy ...

LintonPharm announces authorization from China health authority to proceed with a global Phase 3 trial evaluating Catumaxomab in advanced gastric cancer

- LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell ...

NTHU’s Boron Neutron Capture Therapy Center begins treating overseas brain cancer patients

- On February 14th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the ...

New cancer treatment developed at NTHU

- A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a ...

BBKSDA confirms ensnared Sumatran tiger on path to recovery

A Sumatran tiger (Panthera tigris) that had suffered grave injury in the left leg after being trapped in a hunters' ...